Feb 10, 2020

Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical (NASDAQ:AEMD) Stock

Feb 6, 2020

Aethlon Medical To Release Third Quarter Financial Results and Host Conference Call on February 10, 2020

Jan 22, 2020

Aethlon Medical Announces Completion of $3.77 Million Registered Direct Offering

Jan 17, 2020

Aethlon Medical Announces $3.77 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 17, 2019

Aethlon Medical Announces Closing of $5 Million Public Offering

Dec 13, 2019

Aethlon Medical Announces Pricing of $5 Million Public Offering

Nov 1, 2019

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Oct 29, 2019

Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on November 1, 2019

Oct 14, 2019

Aethlon Announces Reverse Stock Split

Oct 7, 2019

Aethlon Medical Announces FDA Approval Of IDE For Oncology Indications